Literature DB >> 26498570

Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.

Ashok Penta1, Scott Franzblau2, Baojie Wan2, Sankaranarayanan Murugesan3.   

Abstract

Molecular hybridization is an emerging approach to design novel ligands by combination of two or more pharmacophoric subunits of known bioactive compounds. In the present study, we have designed a novel series of diarylpiperazine analogues, synthesized, characterized using FTIR, (1)H NMR, Mass, Elemental analysis and evaluated their in-vitro anti-tubercular activity. Among the reported sixteen diarylpiperazines, eleven analogues exhibited significant anti-tubercular activity against Mycobacterium tuberculosis H37Rv strain with MIC values below 6.25 μg/mL and good selectivity index. Structure activity relationship studies concluded that, ortho-para directing group (except para chloro) substitution on ortho and para position of piperazine attached phenyl ring favored anti-tubercular activity.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Mycobacterium tuberculosis; Piperazine; β-carboline

Mesh:

Substances:

Year:  2015        PMID: 26498570     DOI: 10.1016/j.ejmech.2015.10.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  A dock derived compound against laminin receptor (37 LR) exhibits anti-cancer properties in a prostate cancer cell line model.

Authors:  Charles Samuel Umbaugh; Adriana Diaz-Quiñones; Manoel Figueiredo Neto; Joseph J Shearer; Marxa L Figueiredo
Journal:  Oncotarget       Date:  2017-12-13

2.  Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents.

Authors:  Penta Ashok; Subhash Chander; Terry K Smith; Rajnish Prakash Singh; Prabhat Nath Jha; Murugesan Sankaranarayanan
Journal:  Bioorg Chem       Date:  2018-11-22       Impact factor: 5.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.